Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.09
26.22
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Yixintang Pharmaceutical Group Co Ltd
Total Current Assets
Yixintang Pharmaceutical Group Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Total Current Assets
ÂĄ10.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
||
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Total Current Assets
ÂĄ11.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Total Current Assets
ÂĄ8.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
||
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Total Current Assets
ÂĄ13.9B
|
CAGR 3-Years
24%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Total Current Assets
ÂĄ5.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
||
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
Total Current Assets
ÂĄ2.8B
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Yixintang Pharmaceutical Group Co Ltd
Glance View
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan and currently employs 32,503 full-time employees. The company went IPO on 2014-07-02. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The firm distributes its products through regular chain drugstores. The firm mainly operates its business in domestic market, with southwest area of China as its main market.
See Also
What is Yixintang Pharmaceutical Group Co Ltd's Total Current Assets?
Total Current Assets
10.2B
CNY
Based on the financial report for Jun 30, 2024, Yixintang Pharmaceutical Group Co Ltd's Total Current Assets amounts to 10.2B CNY.
What is Yixintang Pharmaceutical Group Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
15%
Over the last year, the Total Current Assets growth was 11%. The average annual Total Current Assets growth rates for Yixintang Pharmaceutical Group Co Ltd have been 15% over the past three years , 14% over the past five years , and 15% over the past ten years .